Our profiling and comparison on the actions of conolidine and cannabidiol with identified pharmacological brokers predicted a MOA shared with Cav2.2 channel blocker, ω-conotoxin CVIE. In 2011, the halls in the Scripps Analysis Institute in Jupiter, Florida witnessed the inception of the scientific journey that would redefine our comprehension https://anatolm740phw5.frewwebs.com/profile